Although vaccines typically take years to produce, test, and license, US health officials had voiced confidence that Zika would not be a difficult target, and some predicted that a vaccine could be made and fully tested, ready for FDA assessment, within two to three years. Others predicted a licensed Zika vaccine could be available sometime in 2020

Quick Read

The first gene therapy treatment in the United States was approved recently by the Food and Drug Administration, heralding a new era in medicine that is coming faster than most realize — and that perhaps few can afford

Quick Read

Over Humira’s lifetime, AbbVie has secured more than 100 patents to prevent anyone from attempting to copy the biologic, with $16 billion in annual sales

Quick Read

“If I put myself on the list [for a kidney transplant] and just wait, that’s not proactive,” Okun said. “You get on the list and then do nothing, you might get a kidney and you might not get a kidney. And it’s [a wait of] anywhere from five to nine years.”

Quick Read

There are two medications that prevent preterm birth, the most common cause of perinatal death in the U.S. One costs 16 cents a week, one US$285. Poor black women aren’t getting either. Why?

Quick Read

Tasia Smith: “Politicians and scholars sometimes cast obesity as a problem that largely afflicts the poor. But as most obese adults aren’t poor and most low-income adults aren’t obese, this is a misconception”

Quick Read

The US is sitting on one of the largest data sets on any animal group, but most of it is inaccessible and restricted to local agencies

Quick Read

When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like “breakthrough,” “revolutionary” and “a watershed moment.” But when they think about how much the therapy is likely to cost, their tone turns alarmist. “It’s going to cost a fortune,” said Dr. Ivan Borrello at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore

Quick Read